Literature DB >> 6208380

Identification of a new neutralization antigenic site on poliovirus coat protein VP2.

E A Emini, B A Jameson, E Wimmer.   

Abstract

Major neutralization antigenic sites have been previously mapped by us on VP1, the largest capsid protein of poliovirus type 1. Here we report the first identification of the primary sequence of a neutralization antigenic site on capsid protein VP2. Inspection of the amino acid sequence of VP2 led to the selection and synthesis of a peptide (n = 12) that, after linking to a carrier protein, induced an antiviral neutralizing antibody response in rabbits. The response was augmented by a single subsequent inoculation of intact virus; thus, the peptide was also capable of priming the production of neutralizing antibodies. These antibodies were directed only against the site specified by the synthetic peptide. Although the VP2-specific neutralization antigenic site appears not to be strongly immunogenic in the intact virion, it can nevertheless contribute to neutralization of poliovirus. This observation may be important for the development of peptide vaccines.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208380      PMCID: PMC254583     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Investigation of the structure of polio- and human rhinovirions through the use of selective chemical reactivity.

Authors:  K Lonberg-Holm; B E Butterworth
Journal:  Virology       Date:  1976-05       Impact factor: 3.616

2.  Iodination of poliovirus capsid proteins.

Authors:  T W Beneke; K O Habermehl; W Diefenthal; M Buchholz
Journal:  J Gen Virol       Date:  1977-02       Impact factor: 3.891

3.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

4.  O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus.

Authors:  P G Rothberg; T J Harris; A Nomoto; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

5.  Structural and functional role of leucine residues in proteins.

Authors:  P Y Chou; G D Fasman
Journal:  J Mol Biol       Date:  1973-03-05       Impact factor: 5.469

6.  Cleavage sites in the polypeptide precursors of poliovirus protein P2-X.

Authors:  B L Semler; R Hanecak; C W Anderson; E Wimmer
Journal:  Virology       Date:  1981-10-30       Impact factor: 3.616

Review 7.  Structure and expression of the picornavirus genome.

Authors:  N Kitamura; C Adler; E Wimmer
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

8.  Primary structure, gene organization and polypeptide expression of poliovirus RNA.

Authors:  N Kitamura; B L Semler; P G Rothberg; G R Larsen; C J Adler; A J Dorner; E A Emini; R Hanecak; J J Lee; S van der Werf; C W Anderson; E Wimmer
Journal:  Nature       Date:  1981-06-18       Impact factor: 49.962

9.  Induction of neutralizing antibodies by the coxsackievirus B3 virion polypeptide, VP2.

Authors:  S T Beatrice; M G Katze; B A Zajac; R L Crowell
Journal:  Virology       Date:  1980-07-30       Impact factor: 3.616

10.  Topographical studies on poliovirus capsid proteins by chemical modification and cross-linking with bifunctional reagents.

Authors:  K Wetz; K O Habermehl
Journal:  J Gen Virol       Date:  1979-08       Impact factor: 3.891

View more
  10 in total

1.  Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1.

Authors:  K J Wiegers; K Wetz; R Dernick
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

2.  Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.

Authors:  B Blondel; R Crainic; O Fichot; G Dufraisse; A Candrea; D Diamond; M Girard; F Horaud
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

3.  Molecular cloning and complete sequence determination of RNA genome of human rhinovirus type 14.

Authors:  P L Callahan; S Mizutani; R J Colonno
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Trypsin sensitivity of the Sabin strain of type 1 poliovirus: cleavage sites in virions and related particles.

Authors:  C E Fricks; J P Icenogle; J M Hogle
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

5.  Neutralization of poliovirus by polyclonal antibodies requires binding of a single IgG molecule per virion.

Authors:  K Wetz; P Willingmann; H Zeichhardt; K O Habermehl
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

6.  Three-dimensional model of the capsid proteins of two biologically different Theiler virus strains: clustering of amino acid difference identifies possible locations of immunogenic sites on the virion.

Authors:  D C Pevear; M Luo; H L Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  Construction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralization antigenic site II.

Authors:  A D Murdin; E Wimmer
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Characterization of neutralizing antibodies to bovine enterovirus elicited by synthetic peptides.

Authors:  M S Smyth; A Trudgett; E M Hoey; S J Martin; F Brown
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

9.  Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14.

Authors:  B Sherry; A G Mosser; R J Colonno; R R Rueckert
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

10.  Poliovirus genome RNA hybridizes specifically to higher eukaryotic rRNAs.

Authors:  M A McClure; J Perrault
Journal:  Nucleic Acids Res       Date:  1985-10-11       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.